跳至主要内容
临床试验/ACTRN12622001500741
ACTRN12622001500741尚未招募未知

se of mobile phone TEXT messages to increase the adherence of SGLT2 Inhibitors: a MULti-country Effectiveness-Implementation trial (TEXT-STIMULI)

The University of Sydney0 个研究点目标入组 476 人开始时间: 2022年11月30日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
476

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • An indication for SGLT2 Inhibitor (as per Australian and Canadian guidelines at time of assessment).
  • Receiving a first, and ongoing, prescription for an SGLT2 Inhibitor.
  • Access to an operational smart mobile telephone that can send and receive text messages, open multimedia files, and access the Internet.
  • Sufficient English language proficiency to read and understand text messages on a mobile telephone.
  • Willing and able to perform trial related procedures.

排除标准

  • Life expectancy less than 12 months.
  • Already prescribed an SGLT2i more than 3 months prior to assessment.
  • Diagnosed with Type 1 diabetes mellitus or gestational diabetes.

研究者

相似试验

se of mobile phone TEXT messages to increase the... | 临床试验